ロード中...
Second-line treatment in renal cell carcinoma: clinical experience and decision making
Currently, conventional treatments for metastatic RCC (mRCC) include immune-based combination regimens and/or targeted therapies, the latter mainly acting on angiogenesis, a key element of the process of tumor growth and spread. Although these agents proved able to improve patients’ outcomes, drug r...
保存先:
| 出版年: | Ther Adv Urol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216352/ https://ncbi.nlm.nih.gov/pubmed/34211586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562872211022870 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|